Amur, Shashi
33  results:
Search for persons X
?
1

FDA Experience With Regulation of Naloxone Products to Addr..:

Amur, Shashi ; Xu, Yun ; Hertz, Sharon.
Clinical Pharmacology & Therapeutics.  109 (2020)  3 - p. 569-572 , 2020
 
?
2

Evaluating the Use of KIM‐1 in Drug Development and Researc..:

Chen, Ru ; Sanyal, Sarmistha ; Thompson, Aliza...
Clinical Pharmacology & Therapeutics.  104 (2018)  6 - p. 1175-1181 , 2018
 
?
3

Patient-Centered Therapy Development for Myotonic Dystrophy..:

Hesterlee, Sharon ; Amur, Shashi ; Bain, Lisa J....
Therapeutic Innovation & Regulatory Science.  51 (2017)  4 - p. 516-522 , 2017
 
?
4

Path to Regulatory Qualification Program Development:

, In: The Path from Biomarker Discovery to Regulatory Qualification,
Amur, Shashi - p. 169-173 , 2013
 
?
5

Contributors:

, In: The Path from Biomarker Discovery to Regulatory Qualification,
 
?
 
?
 
?
13

Pharmacogenomic Biomarker Information in Drug Labels Approv..:

Frueh, Felix W. ; Amur, Shashi ; Mummaneni, Padmaja...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  28 (2008)  8 - p. 992-998 , 2008
 
1-15